{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T20:58:43Z","timestamp":1791752323906,"version":"4.3.4"},"reference-count":69,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2010,1,1]],"date-time":"2010-01-01T00:00:00Z","timestamp":1262304000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Critical Reviews in Oncology\/Hematology"],"published-print":{"date-parts":[[2010,1]]},"DOI":"10.1016\/j.critrevonc.2008.12.004","type":"journal-article","created":{"date-parts":[[2009,10,5]],"date-time":"2009-10-05T16:04:45Z","timestamp":1254758685000},"page":"31-46","source":"Crossref","is-referenced-by-count":69,"title":["2008 french national guidelines for the treatment of venous thromboembolism in patients with cancer: Report from the working group"],"prefix":"10.1016","volume":"73","author":[{"given":"Dominique","family":"Farge","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lise","family":"Bosquet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diana","family":"Kassab-Chahmi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Mismetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ismail","family":"Elalamy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guy","family":"Meyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francis","family":"Cajfinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H\u00e9l\u00e8ne","family":"Desmurs-Clavel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antoine","family":"Elias","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire","family":"Grange","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hamid","family":"Hocini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gr\u00e9goire","family":"Legal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabelle","family":"Mahe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabelle","family":"Qu\u00e9r\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Herv\u00e9","family":"Levesque","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Debourdeau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.critrevonc.2008.12.004_bib1","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1001\/archinte.164.9.963","article-title":"Risk factors for venous thromboembolism in hospitalized patients with acute medical illness: analysis of the MEDENOX Study","volume":"164","author":"Alikhan","year":"2004","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.critrevonc.2008.12.004_bib2","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1001\/archinte.160.6.809","article-title":"Risk factors for deep vein thrombosis and pulmonary embolism: a population-based case-control study","volume":"160","author":"Heit","year":"2000","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.critrevonc.2008.12.004_bib3","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1001\/.458","article-title":"Incidence of venous thromboembolism and its effect on survival among patients with common cancers","volume":"166","author":"Chew","year":"2006","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.critrevonc.2008.12.004_bib4","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/S0248-8663(00)80046-6","article-title":"Maladie thromboembolique veineuse et cancer","volume":"21","author":"Sauve","year":"2000","journal-title":"Rev Med Intern"},{"key":"10.1016\/j.critrevonc.2008.12.004_bib5","doi-asserted-by":"crossref","first-page":"1782","DOI":"10.1001\/archinte.165.15.1782","article-title":"Incidence of venous thromboembolism in the year before the diagnosis of cancer in 528,693 adults","volume":"165","author":"White","year":"2005","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.critrevonc.2008.12.004_bib6","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1200\/JCO.2005.04.2150","article-title":"Venous thromboembolism in patients with colorectal cancer: incidence and effect on survival","volume":"24","author":"Alcalay","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.critrevonc.2008.12.004_bib7","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1200\/JCO.2005.03.8877","article-title":"Thromboembolism in hospitalized neutropenic cancer patients","volume":"24","author":"Khorana","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.critrevonc.2008.12.004_bib8","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/j.thromres.2005.10.015","article-title":"Chemotherapy-induced thrombosis","volume":"118","author":"Haddad","year":"2006","journal-title":"Thromb Res"},{"key":"10.1016\/j.critrevonc.2008.12.004_bib9","doi-asserted-by":"crossref","first-page":"1846","DOI":"10.1056\/NEJM200012213432504","article-title":"Prognosis of cancers associated with venous thromboembolism","volume":"343","author":"Sorensen","year":"2000","journal-title":"N Engl J Med"},{"issue":"3 Suppl.","key":"10.1016\/j.critrevonc.2008.12.004_bib10","doi-asserted-by":"crossref","first-page":"401S","DOI":"10.1378\/chest.126.3_suppl.401S","article-title":"Antithrombotic therapy for venous thromboembolic disease: the seventh ACCP conference on antithrombotic and thrombolytic therapy","volume":"126","author":"Buller","year":"2004","journal-title":"Chest"},{"key":"10.1016\/j.critrevonc.2008.12.004_bib11","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.critrevonc.2006.05.001","article-title":"Venous thromboembolism and cancer: guidelines of the Italian Association of Medical Oncology (AIOM)","volume":"59","author":"Mandala","year":"2006","journal-title":"Crit Rev Oncol Hematol"},{"issue":"Suppl. 2","key":"10.1016\/j.critrevonc.2008.12.004_bib12","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1054\/bjoc.2000.1757","article-title":"SOR: project methodology","volume":"84","author":"Fervers","year":"2001","journal-title":"Br J Cancer"},{"key":"10.1016\/j.critrevonc.2008.12.004_bib13","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1136\/qhc.12.1.18","article-title":"Development and validation of an international appraisal instrument for assessing the quality of clinical practice guidelines: the AGREE project","volume":"12","year":"2003","journal-title":"Qual Saf Health Care"},{"key":"10.1016\/j.critrevonc.2008.12.004_bib14","unstructured":"French national cancer institute. Available at: http:\/\/www.e-cancer.fr\/."},{"key":"10.1016\/j.critrevonc.2008.12.004_bib15","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1111\/j.1538-7836.2005.01204.x","article-title":"Subcommittee on Control of Anticoagulation of the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis. Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non-surgical patients","volume":"3","author":"Schulman","year":"2005","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.critrevonc.2008.12.004_bib16","unstructured":"Cucherat M. Guide de lecture critique d\u2019un essai th\u00e9rapeutique. M\u00e9decine Th\u00e9rapeutique 2006;12:354\u20138. Available at: http:\/\/www.spc.univ-lyon1.fr\/lecture-critique\/grille%20de%20lecture\/frame1.htm\/."},{"key":"10.1016\/j.critrevonc.2008.12.004_bib17","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1007\/BF02016754","article-title":"Thromboembolic complications in patients with advanced cancer: anticoagulation versus Greenfield filter placement","volume":"5","author":"Calligaro","year":"1991","journal-title":"Ann Vasc Surg"},{"key":"10.1016\/j.critrevonc.2008.12.004_bib18","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1111\/j.1445-5994.1992.tb02789.x","article-title":"Complications and failure of anticoagulation therapy in the treatment of venous thromboembolism in patients with disseminated malignancy","volume":"22","author":"Chan","year":"1992","journal-title":"Aust N Z J Med"},{"key":"10.1016\/j.critrevonc.2008.12.004_bib19","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/0248-8663(96)81247-1","article-title":"Traitement anticoagulant classique de la maladie thromboembolique veineuse chez les patients canc\u00e9reux. A propos d\u2019une s\u00e9rie r\u00e9trospective de 71 patients","volume":"17","author":"Debourdeau","year":"1996","journal-title":"Rev Med Intern"},{"key":"10.1016\/j.critrevonc.2008.12.004_bib20","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1016\/j.amjmed.2006.02.022","article-title":"Long-term low-molecular-weight heparin versus usual care in proximal-vein thrombosis patients with cancer","volume":"119","author":"Hull","year":"2006","journal-title":"Am J Med"},{"key":"10.1016\/j.critrevonc.2008.12.004_bib21","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1001\/archinte.155.6.601","article-title":"Treatment of deep venous thrombosis with low-molecular-weight heparins. A meta-analysis","volume":"155","author":"Lensing","year":"1995","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.critrevonc.2008.12.004_bib22","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/S0002-9343(97)89484-3","article-title":"Low-molecular-weight heparins and unfractionated heparin in the treatment of patients with acute venous thromboembolism: results of a meta-analysis","volume":"100","author":"Siragusa","year":"1996","journal-title":"Am J Med"},{"key":"10.1016\/j.critrevonc.2008.12.004_bib23","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1097\/00063198-199807000-00007","article-title":"Low molecular weight heparin versus unfractionated heparin in the initial treatment of venous thromboembolism","volume":"4","author":"Hettiarachchi","year":"1998","journal-title":"Curr Opin Pulm Med"},{"key":"10.1016\/j.critrevonc.2008.12.004_bib24","doi-asserted-by":"crossref","first-page":"800","DOI":"10.7326\/0003-4819-130-10-199905180-00003","article-title":"Low-molecular-weight heparins compared with unfractionated heparin for treatment of acute deep venous thrombosis. A meta-analysis of randomized, controlled trials","volume":"130","author":"Gould","year":"1999","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.critrevonc.2008.12.004_bib25","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1001\/archinte.160.2.181","article-title":"A meta-analysis comparing low-molecular-weight heparins with unfractionated heparin in the treatment of venous thromboembolism: examining some unanswered questions regarding location of treatment, product type, and dosing frequency","volume":"160","author":"Dolovich","year":"2000","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.critrevonc.2008.12.004_bib26","first-page":"935","article-title":"Do the low molecular weight heparins improve efficacy and safety of the treatment of deep venous thrombosis? A meta-analysis","volume":"85","author":"Rocha","year":"2000","journal-title":"Haematologica"},{"key":"10.1016\/j.critrevonc.2008.12.004_bib27","doi-asserted-by":"crossref","first-page":"175","DOI":"10.7326\/0003-4819-140-3-200402030-00008","article-title":"Low-molecular-weight heparin compared with intravenous unfractionated heparin for treatment of pulmonary embolism: a meta-analysis of randomized, controlled trials","volume":"140","author":"Quinlan","year":"2004","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.critrevonc.2008.12.004_bib28","doi-asserted-by":"crossref","first-page":"2203","DOI":"10.1378\/chest.128.4.2203","article-title":"Enoxaparin in the treatment of deep vein thrombosis with or without pulmonary embolism: an individual patient data meta-analysis","volume":"128","author":"Mismetti","year":"2005","journal-title":"Chest"},{"key":"10.1016\/j.critrevonc.2008.12.004_bib29","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1097\/00000421-200002000-00020","article-title":"Warfarin is safe as secondary prophylaxis in patients with cancer and a previous episode of venous thrombosis","volume":"23","author":"Bona","year":"2000","journal-title":"Am J Clin Oncol"},{"key":"10.1016\/j.critrevonc.2008.12.004_bib30","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1055\/s-0037-1614120","article-title":"A comparison of the safety and efficacy of oral anticoagulation for the treatment of venous thromboembolic disease in patients with or without malignancy","volume":"84","author":"Palareti","year":"2000","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.critrevonc.2008.12.004_bib31","doi-asserted-by":"crossref","first-page":"3484","DOI":"10.1182\/blood-2002-01-0108","article-title":"Recurrent venous thromboembolism and bleeding complications during anticoagulant treatment in patients with cancer and venous thrombosis","volume":"100","author":"Prandoni","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.critrevonc.2008.12.004_bib32","first-page":"296","article-title":"Treatment of deep vein thrombosis with oral anticoagulants in patients with malignancy: prospective cohort study","volume":"43","author":"Vucic","year":"2002","journal-title":"Croat Med J"},{"key":"10.1016\/j.critrevonc.2008.12.004_bib33","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1001\/archinte.162.15.1729","article-title":"Comparison of low-molecular-weight heparin and warfarin for the secondary prevention of venous thromboembolism in patients with cancer: a randomized controlled study","volume":"162","author":"Meyer","year":"2002","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.critrevonc.2008.12.004_bib34","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1056\/NEJMoa025313","article-title":"Low-molecular-weight heparin versus a coumarin for the prevention of recurrent venous thromboembolism in patients with cancer","volume":"349","author":"Lee","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.critrevonc.2008.12.004_bib35","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1177\/1076029606293692","article-title":"Secondary prevention of venous thromboembolic events in patients with active cancer: enoxaparin alone versus initial enoxaparin followed by warfarin for a 180-day period","volume":"12","author":"Deitcher","year":"2006","journal-title":"Clin Appl Thromb Hemost"},{"key":"10.1016\/j.critrevonc.2008.12.004_bib36","doi-asserted-by":"crossref","first-page":"1808","DOI":"10.1378\/chest.130.6.1808","article-title":"Is recurrent venous thromboembolism after therapy reduced by low-molecular-weight heparin compared with oral anticoagulants?","volume":"130","author":"Ferretti","year":"2006","journal-title":"Chest"},{"key":"10.1016\/j.critrevonc.2008.12.004_bib37","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.1046\/j.1538-7836.2003.00364.x","article-title":"Low-molecular-weight heparin for the long-term treatment of symptomatic venous thromboembolism: meta-analysis of the randomized comparisons with oral anticoagulants","volume":"1","author":"Iorio","year":"2003","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.critrevonc.2008.12.004_bib38","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1191\/0269216305pm1008oa","article-title":"Is long-term low-molecular-weight heparin acceptable to palliative care patients in the treatment of cancer related venous thromboembolism? A qualitative study","volume":"19","author":"Noble","year":"2005","journal-title":"Palliat Med"},{"key":"10.1016\/j.critrevonc.2008.12.004_bib39","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1136\/bmj.38733.616065.802","article-title":"Acceptability of low molecular weight heparin thromboprophylaxis for inpatients receiving palliative care: qualitative study","volume":"332","author":"Noble","year":"2006","journal-title":"BMJ"},{"key":"10.1016\/j.critrevonc.2008.12.004_bib40","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/S0002-8703(97)70041-3","article-title":"Attenuation over 24h of the efficacy of thrombolysis of pulmonary embolism among patients with cancer","volume":"134","author":"Mikkola","year":"1997","journal-title":"Am Heart J"},{"key":"10.1016\/j.critrevonc.2008.12.004_bib41","first-page":"12","article-title":"Greenfield filter as primary therapy for deep venous thrombosis and\/or pulmonary embolism in patients with cancer","volume":"109","author":"Cohen","year":"1991","journal-title":"Surgery"},{"key":"10.1016\/j.critrevonc.2008.12.004_bib42","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1002\/1097-0142(19921001)70:7<1993::AID-CNCR2820700731>3.0.CO;2-V","article-title":"Greenfield filter instead of heparin as primary treatment for deep venous thrombosis or pulmonary embolism in patients with cancer","volume":"70","author":"Cohen","year":"1992","journal-title":"Cancer"},{"key":"10.1016\/j.critrevonc.2008.12.004_bib43","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1097\/00000421-199404000-00005","article-title":"The Bird's Nest Filter. An alternative to long-term oral anticoagulation in patients with advanced malignancies","volume":"17","author":"Hubbard","year":"1994","journal-title":"Am J Clin Oncol"},{"key":"10.1016\/j.critrevonc.2008.12.004_bib44","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1200\/JCO.1996.14.2.652","article-title":"Inferior vena cava filters in cancer patients: indications and outcome","volume":"14","author":"Schwarz","year":"1996","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.critrevonc.2008.12.004_bib45","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/S0967-2109(97)00005-7","article-title":"Clinical results of Greenfield filter use in patients with cancer","volume":"5","author":"Greenfield","year":"1997","journal-title":"Cardiovasc Surg"},{"key":"10.1016\/j.critrevonc.2008.12.004_bib46","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1016\/S0741-5214(98)70054-0","article-title":"Treatment of patients with venous thromboembolism and malignant disease: should vena cava filter placement be routine?","volume":"28","author":"Ihnat","year":"1998","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.critrevonc.2008.12.004_bib47","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1016\/S0741-5214(02)00121-0","article-title":"Inferior vena cava filters in malignant disease","volume":"36","author":"Jarrett","year":"2002","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.critrevonc.2008.12.004_bib48","doi-asserted-by":"crossref","first-page":"1902","DOI":"10.1002\/cncr.20578","article-title":"Use of inferior vena caval filters and survival in patients with malignancy","volume":"101","author":"Wallace","year":"2004","journal-title":"Cancer"},{"key":"10.1016\/j.critrevonc.2008.12.004_bib49","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1590\/S1807-59322005000500003","article-title":"Vena cava filters in cancer patients: experience with 50 patients","volume":"60","author":"Zerati","year":"2005","journal-title":"Clinics"},{"key":"10.1016\/j.critrevonc.2008.12.004_bib50","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1177\/1538574406291821","article-title":"Inferior vena cava filter placement in late-stage cancer","volume":"40","author":"Schunn","year":"2006","journal-title":"Vasc Endovasc Surg"},{"key":"10.1016\/j.critrevonc.2008.12.004_bib51","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1007\/s00415-002-0855-5","article-title":"Low molecular weight heparin for deep vein thrombosis in glioma patients","volume":"249","author":"Schmidt","year":"2002","journal-title":"J Neurol"},{"key":"10.1016\/j.critrevonc.2008.12.004_bib52","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1227\/00006123-199007000-00010","article-title":"The risk and efficacy of anticoagulant therapy in the treatment of thromboembolic complications in patients with primary malignant brain tumors","volume":"27","author":"Altschuler","year":"1990","journal-title":"Neurosurgery"},{"key":"10.1016\/j.critrevonc.2008.12.004_bib53","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1212\/WNL.43.6.1111","article-title":"Complications of therapy for venous thromboembolic disease in patients with brain tumors","volume":"43","author":"Levin","year":"1993","journal-title":"Neurology"},{"key":"10.1016\/j.critrevonc.2008.12.004_bib54","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1002\/1097-0142(19940115)73:2<493::AID-CNCR2820730240>3.0.CO;2-D","article-title":"Therapy of venous thromboembolism in patients with brain metastases","volume":"73","author":"Schiff","year":"1994","journal-title":"Cancer"},{"key":"10.1016\/j.critrevonc.2008.12.004_bib55","unstructured":"NCCN (national comprehensive cancer network). Venous thromboembolic disease. NCCN Clinical Practice Guidelines in Oncology, ed.; 2006. Available at: http:\/\/www.nccn.org."},{"key":"10.1016\/j.critrevonc.2008.12.004_bib56","unstructured":"Scully MF, Geerts WH, Kovacs M, Lee A. Clinical guide \u2013 cancer & thrombosis. The Thrombosis Interest Group of Canada, ed. 08\/5 A.D. Available: http:\/\/www.tigc.org."},{"key":"10.1016\/j.critrevonc.2008.12.004_bib57","doi-asserted-by":"crossref","first-page":"5490","DOI":"10.1200\/JCO.2007.14.1283","article-title":"American Society of Clinical Oncology guideline: recommendations for venous thromboembolism prophylaxis and treatments in patients with cancer","volume":"25","author":"Lyman","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.critrevonc.2008.12.004_bib58","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1055\/s-0037-1615937","article-title":"Do heparins do more than just treat thrombosis? The influence of heparins on cancer spread","volume":"82","author":"Hettiarachchi","year":"1999","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.critrevonc.2008.12.004_bib59","doi-asserted-by":"crossref","first-page":"593","DOI":"10.2165\/00019053-200624060-00006","article-title":"Dalteparin versus warfarin for the prevention of recurrent venous thromboembolic events in cancer patients: a pharmacoeconomic analysis","volume":"24","author":"Dranitsaris","year":"2006","journal-title":"Pharmacoeconomics"},{"key":"10.1016\/j.critrevonc.2008.12.004_bib60","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1056\/NEJM199802123380701","article-title":"A clinical trial of vena caval filters in the prevention of pulmonary embolism in patients with proximal deep-vein thrombosis. Prevention du Risque d\u2019Embolie Pulmonaire par Interruption Cave Study Group","volume":"338","author":"Decousus","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1016\/j.critrevonc.2008.12.004_bib61","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1002\/ana.410130320","article-title":"Incidence and treatment of peripheral venous thrombosis in patients with glioma","volume":"13","author":"Ruff","year":"1983","journal-title":"Ann Neurol"},{"key":"10.1016\/j.critrevonc.2008.12.004_bib62","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1055\/s-0038-1649592","article-title":"Venous thromboembolism and high grade gliomas","volume":"70","author":"Dhami","year":"1993","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.critrevonc.2008.12.004_bib63","doi-asserted-by":"crossref","first-page":"2621","DOI":"10.1002\/1097-0142(19911215)68:12<2621::AID-CNCR2820681218>3.0.CO;2-7","article-title":"The incidence and significance of thromboembolic complications in patients with high-grade gliomas","volume":"68","author":"Cheruku","year":"1991","journal-title":"Cancer"},{"key":"10.1016\/j.critrevonc.2008.12.004_bib64","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/S0025-6196(12)62216-2","article-title":"Thromboembolism in patients with high-grade glioma","volume":"69","author":"Quevedo","year":"1994","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.critrevonc.2008.12.004_bib65","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1227\/00006123-198002000-00004","article-title":"Incidence of lower extremity deep vein thrombosis in neurosurgical patients","volume":"6","author":"Valladares","year":"1980","journal-title":"Neurosurgery"},{"key":"10.1016\/j.critrevonc.2008.12.004_bib66","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1097\/00063198-200109000-00013","article-title":"Thromboembolism in brain tumors","volume":"7","author":"Walsh","year":"2001","journal-title":"Curr Opin Pulm Med"},{"issue":"6 Suppl.","key":"10.1016\/j.critrevonc.2008.12.004_bib67","doi-asserted-by":"crossref","first-page":"454S","DOI":"10.1378\/chest.08-0658","article-title":"American College of Chest Physicians. Antithrombotic therapy for venous thromboembolic disease: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th ed.)","volume":"133","author":"Kearon","year":"2008","journal-title":"Chest"},{"issue":"1","key":"10.1016\/j.critrevonc.2008.12.004_bib68","first-page":"CD006649","article-title":"Anticoagulation for the initial treatment of venous thromboembolism in patients with cancer","author":"Akl","year":"2008","journal-title":"Cochrane Database Syst Rev"},{"issue":"2","key":"10.1016\/j.critrevonc.2008.12.004_bib69","first-page":"CD006650","article-title":"Anticoagulation for the long term treatment of venous thromboembolism in patients with cancer","author":"Akl","year":"2008","journal-title":"Cochrane Database Syst Rev"}],"container-title":["Critical Reviews in Oncology\/Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1040842808003065?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1040842808003065?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,5,22]],"date-time":"2020-05-22T20:04:43Z","timestamp":1590177883000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1040842808003065"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,1]]},"references-count":69,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010,1]]}},"alternative-id":["S1040842808003065"],"URL":"https:\/\/doi.org\/10.1016\/j.critrevonc.2008.12.004","relation":{},"ISSN":["1040-8428"],"issn-type":[{"value":"1040-8428","type":"print"}],"subject":[],"published":{"date-parts":[[2010,1]]}}}